Purpose Current treatments for coronavirus disease 2019 (COVID-19) lung disease have
limited efficacy. Low-dose radiation therapy (LDRT) has received both interest and criticism …

The limited impact of treatments for COVID-19 has stimulated several phase 1 clinical trials
of whole-lung low-dose radiation therapy (LDRT; 0.3–1.5 Gy) that are now progressing to …

The novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has had a devastating impact, with the number of …

Objectives: The World Health Organization (WHO) has declared coronavirus disease 2019
(COVID-19) as pandemic in March 2020. Currently there is no specific effective treatment for …

The COVID-19 pandemia is affecting people worldwide. Most of the patients suffered of a
respiratory disease that will progress to an acute respiratory distress syndrome (ARDS) …

Abstract Coronavirus disease-2019 (COVID-19) has become a global health crisis. Mortality
associated with COVID-19 is characterized mainly by acute respiratory distress syndrome …

The COVID-19 pneumonia is a devastating disease without any approved treatment until
now [1]. Kirkby and Mackenzie discussed the potential of lungs low dose radiation therapy …

Fatal cases of COVID-19 are characterised by acute respiratory distress syndrome (ARDS),
sepsis, pneumonia and respiratory failure [1]. The high transmission rate of the virus and the …

Purpose The morbidity and mortality of patients requiring mechanical ventilation for
coronavirus disease 2019 (COVID-19) pneumonia is considerable. We studied the use of …

Purpose Low-dose radiation therapy (LD-RT) has been shown to have an anti-inflammatory
effect, and preliminary results suggest it is feasible to treat patients with coronavirus disease …